Vaqta is a highly effective vaccine designed to prevent hepatitis A, a liver infection caused by the hepatitis A virus. This vaccine is inactivated, ensuring safety and efficacy for users. It is administered intramuscularly and is available in a prefilled syringe format for ease of use.
Key FeaturesVaqta is indicated for individuals 19 years and older, providing robust protection against hepatitis A. It is especially recommended for travelers to areas with poor sanitation, healthcare workers, and individuals with chronic liver conditions.
About the BrandMerck, the manufacturer of Vaqta, is a leading authority in vaccine development, known for its innovative approaches and commitment to public health. With a strong heritage in pharmaceutical advancements, Merck continues to pioneer in the vaccine space, ensuring safety and efficacy in all its products.